Colin Goodchild, Chairman
MA (Cantab), MB, BChir, PhD, FRCA, FANZCA, FFPMANZCA
Colin is a co‐founder of Drawbridge and serves as Chief Medical Officer. He is a UK medical graduate from Cambridge University with a PhD in neuroscience from the University of Leeds. He is a specialist in anaesthesia & pain medicine and holds post graduate diplomas from the Royal College of Anaesthetists in London, UK and also from the Australia & NZ College of Anaesthetists and its Faculty of Pain Medicine. He has published in excess of 100 publications in major international journals in his field.
Colin is very active clinically in providing anaesthesia for surgery and as a tertiary referral Pain Medicine Specialist. He is well known as an inventor in anaesthesia and analgesia being listed inventor on 17 patents which have been licensed for development and commercialisation to various companies including: Purdue Frederick; Vernalis; Balboa Biosciences; and CNSBio. He has held the positions of Director and CSO at CNSBio Pty Ltd. Colin is recognised as a leader in translational medicine, combining knowledge and skills as a neuroscientist, clinician, practising anaesthetist and entrepreneur.
Click for Researchgate profile
Juliet is the inventor of the Phaxan™ technology, a co‐founder of Drawbridge and serves as its Chief Product Officer. Juliet is a medical graduate and specialist in anaesthesia & pain medicine having a diploma from the Royal College of Anaesthetists in London, UK. She has a broad range of medical practice experience, having practised in three continents (India, Europe and Australia). Juliet also has a PhD in neuroscience from the University of Leeds.
Juliet is an author of several scientific papers published in major international peer reviewed journals in the fields of anaesthesia and pain medicine under her professional surname Dr Serrao.
David is an experienced company director with more than 30 years of industry experience spanning large public and private healthcare companies encompassing roles in risk management, compliance and governance. Dr Page is also a specialist anaesthetist who has performed more than 40,000 inductions and represents a group of investors who have taken an equity position in Drawbridge. From October 2011 to August 2013 he was Chairman of Norwest Private anaesthetic department with 150 members, participating in Medical Advisory Committee and Pharmacy Committees, leading department and clinical review meetings and mentoring. From January 2016 he has led the corporate advisory board for home located aged and dementia care provider Focus Care Solutions, responsible for mentoring the CEO in building a successful organisation, now with over 45 employees.
He received an MBBS from the University of Sydney in 1982, held a Fellowship of the ANZCA from 1992‐2002, is a member of the Australian Society of Anaesthetists and is a Graduate of the Australian Institute of Company Directors.